Auspice Ltd 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 06:40 am Unchanged | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Auspice Ltd | 941,206 1.960% | 0 (Unchanged) | Filing |
| 2023-02-09 06:15 am Sale | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Auspice Ltd | 941,206 1.960% | -470,000 (-33.30%) | Filing |
| 2022-04-06 10:27 am Purchase | 2022-04-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Auspice Ltd | 1,411,206 5.600% | 1,411,206 (New Position) | Filing |